These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8273589)

  • 1. Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level.
    Young P; McDonnell P; Dunnington D; Hand A; Laydon J; Lee J
    Agents Actions; 1993; 39 Spec No():C67-9. PubMed ID: 8273589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of interleukin-1 (IL-1) and tumor necrosis factor (TNF) production by pyridinyl imidazole compounds is independent of cAMP elevating mechanisms.
    Kassis S; Prabhakar U; Lee JC
    Agents Actions; 1993; 39 Spec No():C64-6. PubMed ID: 7506004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of SK&F 86002 on cytokine production by human monocytes.
    Lee JC; Rebar L; Laydon JT
    Agents Actions; 1989 Jun; 27(3-4):277-9. PubMed ID: 2678952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pyridinyl imidazole compounds on murine TNF-alpha production.
    Olivera DL; Laydon JT; Hillegass L; Badger AM; Lee JC
    Agents Actions; 1993; 39 Spec No():C55-7. PubMed ID: 8273586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of bicyclic imidazoles defines a translational regulatory pathway for tumor necrosis factor alpha.
    Prichett W; Hand A; Sheilds J; Dunnington D
    J Inflamm; 1995; 45(2):97-105. PubMed ID: 7583362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CD44, CD45 and LFA-3 mediated cytokine release from human monocytes by SK&F 86002 and pentoxifylline.
    Prabhakar U; Lipshutz D; Truneh A
    Int J Immunopharmacol; 1993 Feb; 15(2):205-9. PubMed ID: 7682199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of SK&F 86002 on monocyte IL-1 production.
    Lee JC; Votta B; Griswold DE; Hanna N
    Agents Actions; 1989 Jun; 27(3-4):280-1. PubMed ID: 2801311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of interleukin-1 beta production by SKF86002: evidence of two sites of in vitro activity and of a time and system dependence.
    Perregaux DG; Dean D; Cronan M; Connelly P; Gabel CA
    Mol Pharmacol; 1995 Sep; 48(3):433-42. PubMed ID: 7565623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002.
    Lee JC; Griswold DE; Votta B; Hanna N
    Int J Immunopharmacol; 1988; 10(7):835-43. PubMed ID: 3148560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of IL-1 beta synthesis and secretion in human blood monocytes stimulated with bacterial cell wall products.
    Chin J; Kostura MJ
    J Immunol; 1993 Nov; 151(10):5574-85. PubMed ID: 8228247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of SK&F 86002 on cytokine-stimulated IL6 production in cultured neonatal mouse calvaria and SaOS2 osteoblastic cells: the role of prostaglandins and other mechanisms of action.
    Blanque R; Cottereaux C; Gardner CR
    Drugs Exp Clin Res; 1997; 23(2):63-70. PubMed ID: 9309381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine suppressive anti-inflammatory compounds inhibit bone resorption in vitro.
    Votta BJ; Bertolini DR
    Bone; 1994; 15(5):533-8. PubMed ID: 7980964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced endotoxin-induced production of tumor necrosis factor activity by equine peritoneal macrophages exposed to the dual inhibitor of arachidonic acid metabolism, SK & F 86002.
    Morris DD; Crowe N; Moore JN
    Can J Vet Res; 1992 Apr; 56(2):110-4. PubMed ID: 1591653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridinyl imidazoles inhibit the inflammatory phase of delayed type hypersensitivity reactions without affecting T-dependent immune responses.
    Reddy MP; Webb EF; Cassatt D; Maley D; Lee JC; Griswold DE; Truneh A
    Int J Immunopharmacol; 1994 Oct; 16(10):795-804. PubMed ID: 7843851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KE-758, an active metabolite of the new anti-rheumatic drug KE-298, suppresses production of tumor necrosis factor-alpha and interleukin-1 beta in THP-1, a human monocyte cell line.
    Sugimoto M; Inoue T; Yamashita M; Takeshita K; Nakaike S
    Drugs Exp Clin Res; 2002; 28(5):197-205. PubMed ID: 12635495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of bisbenzylisoquinoline alkaloids on induction of proinflammatory cytokines, interleukin-1 and tumor necrosis factor-alpha.
    Onai N; Tsunokawa Y; Suda M; Watanabe N; Nakamura K; Sugimoto Y; Kobayashi Y
    Planta Med; 1995 Dec; 61(6):497-501. PubMed ID: 8824940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.
    Essner R; Rhoades K; McBride WH; Morton DL; Economou JS
    J Immunol; 1989 Jun; 142(11):3857-61. PubMed ID: 2785566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.
    Jang CH; Choi JH; Byun MS; Jue DM
    Rheumatology (Oxford); 2006 Jun; 45(6):703-10. PubMed ID: 16418198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of prostaglandin H synthase 2 expression in human monocytes by the marine natural products manoalide and scalaradial. Novel effects independent of inhibition of lipid mediator production.
    Glaser KB; Lock YW
    Biochem Pharmacol; 1995 Sep; 50(7):913-22. PubMed ID: 7575673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-alpha and IL-1 beta production by human monocytes.
    Shapira L; Takashiba S; Champagne C; Amar S; Van Dyke TE
    J Immunol; 1994 Aug; 153(4):1818-24. PubMed ID: 7519214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.